Valor202020212022202320242025Total de passivos60.72 M301.33 M273.6 M478.39 M948.74 M881.88 MCapital total461.78 M408.82 M418.34 M287.16 M191.06 M503.42 MTotal de passivos e patrimônio líquido522.5 M710.15 M691.94 M765.55 M1.14 B1.39 BDívida total————393.18 M254.88 MDívida líquida————-185.09 M-437.94 M
Arrowhead Pharmaceuticals, Inc. - Common Stock
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.